New Hampshire · 2025 Regular Session · Bill
SB 253: relative to participation in the federal 340B Drug Pricing Program.
Did not advance Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
- Did not advance
Last official action: ·Record last updated:
Plain-language summary
SB 253 is a bill introduced in the New Hampshire Senate on January 23, 2025. According to its official title, it concerns: relative to participation in the federal 340B Drug Pricing Program. Primary sponsor: Tara Reardon (Democratic). It lists 1 additional sponsor. Most recent recorded action (March 6, 2025): Inexpedient to Legislate, MA, VV === BILL KILLED ===; 03/06/2025; SJ 6.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 1 · Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Tara Reardon | Primary sponsor | Democratic | Senate | 15 |
| Bill Gannon | Co-sponsor | Republican | Senate | 23 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Inexpedient to Legislate, MA, VV === BILL KILLED ===; 03/06/2025; SJ 6
- Committee Report: Inexpedient to Legislate, 03/06/2025, Vote 3-2; SC 11
- Hearing: 02/19/2025, Room 100, SH, 09:45 am; SC 10
- Introduced 01/09/2025 and Referred to Health and Human Services; SJ 3